Is JPMorgan (JPM) a Strong Buy Ahead of Earnings?

NYSE: JPM | JPMorgan Chase & Co. News, Ratings, and Charts

JPM – JPMorgan & Chase (JPM), America’s largest bank by assets, will publish its first-quarter earnings on April 12. The bank is expected to report revenue and earnings growth over the prior-year quarter. Therefore, is the stock a strong buy ahead of its earnings? Read on to learn my view…

JPMorgan Chase & Co. (JPM) is scheduled to report its first-quarter results on April 12. Wall Street expects the bank to post higher revenue and earnings in the first quarter. With interest rates at their highest level in 22 years, investors would be interested to know how it has impacted the banks’ financial performance.

With JPM’s earnings expected shortly, I have discussed why waiting for an opportune entry point in the stock could be wise.

For the first quarter, JPM’s EPS and revenue are expected to increase 0.6% and 8.8% year-over-year to $4.13 and $41.72 billion, respectively. The company has a solid earnings history, beating the consensus estimate in three of the trailing four quarters. Fiscal 2023 was a record-breaking year for the bank, as its net income and net interest income set new records.

In a statement, JPM’s CEO Jamie Dimon, said, “The U.S. economy continues to be resilient, with consumers still spending, and markets currently expect a soft landing. It is important to note that the economy is being fueled by large amounts of government deficit spending and past stimulus. This may lead inflation to be stickier and rats to be higher than markets expect.”

For fiscal 2024, JPM expects net-interest income excluding markets of about $88 billion, which is higher than analysts’ estimates of $86.50 billion. KBW analyst Chris McGratty expects the bank to boost its net interest income forecast to $91.10 billion from $90 billion, while the analyst consensus estimate is $90.70 billion.

JPM’s stock has gained 14.6% over the past three months and 54.7% over the past year to close the last trading session at $197.45.

Here’s what you might want to consider ahead of its upcoming earnings release:

Mixed Financials

JPM’s net income for the fourth quarter ended December 31, 2023, declined 15.5% year-over-year to $9.31 billion. In addition, its EPS came in at $3.04, representing a decrease of 14.8% year-over-year. Its return on common equity (ROE) was 12%, compared to 16% in the year-ago quarter. In addition, its provision for credit losses increased 20.7% year-over-year to $2.76 billion.

On the other hand, its total net revenue – reported increased 11.7% year-over-year to $38.57 billion. The company’s net interest income rose 19.1% over the prior-year quarter to $24.05 billion. Its CET1 ratio was 15%, compared to 13.2% in the prior-year quarter.

For the fiscal year ended December 31, 2023, JPM’s total net revenue rose 22.9% year-over-year to $158.10 billion. Its net interest income increased 33.8% over the prior-year period to $89.27 billion. The company’s net income increased 31.5% year-over-year to $49.55 billion. Also, its EPS came in at $16.23, representing an increase of 34.2% year-over-year. In addition, its return on common equity (ROE) was 17%, compared to 14% in the year-ago quarter.

On the other hand, its provision for credit losses rose 45.9% year-over-year to $9.32 billion.

Mixed Analyst Estimates

Analysts expect JPM’s EPS for fiscal 2024 to decline 1.9% year-over-year to $15.92. Its revenue for fiscal 2024 is expected to increase 3.1% year-over-year to $162.98 billion. Its EPS and revenue for fiscal 2025 are expected to increase 1.7% and 0.4% year-over-year to $16.19 and $163.64 billion, respectively.

High Profitability

In terms of the trailing-12-month net income margin, JPM’s 33.94% is 43.9% higher than the 23.59% industry average. Likewise, its 16.89% trailing-12-month Return on Common Equity is 54.5% higher than the industry average of 10.94%. Furthermore, the stock’s 1.28% trailing-12-month Return on Total Assets is 17.7% higher than the industry average of 1.09%.

Stretched Valuation

In terms of forward Price/Sales, JPM’s 3.49x is 39.9% higher than the 2.49x industry average. Its 1.73x forward Price/Book is 66.9% higher than the 1.04x industry average. Additionally, its 3.10x forward non-GAAP PEG is 135.5% higher than the 1.32x industry average.

POWR Ratings Reflect Uncertainty

JPM has an overall rating of C, equating to a Neutral in our POWR Ratings system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.

Our proprietary rating system also evaluates each stock based on eight distinct categories. JPM has a D grade for Value, consistent with its stretched valuation. Its stock is trading below its 10-day moving average but above its 200-day moving average, justifying its C grade for Momentum.

It has a C grade for Sentiment, in sync with its mixed analyst estimates.

JPM is ranked #2 out of 9 stocks in the Money Center Banks industry. Click here to access JPM’s Growth, Stability, and Quality ratings.

Bottom Line

Despite the challenging operating environment, JPM’s earnings and revenue are expected to beat analyst estimates in the first quarter. The bank’s fiscal 2024 prospects appear promising due to the higher-than-expected net interest income forecast. While deal-making shows signs of picking up, the timeline for normalizing M&A activity remains uncertain.

Moreover, the central bank’s three interest rate cuts expected this year will likely decrease the bank’s net interest income compared to last year. Taking out the strong loan growth expected in Card, the bank expects loan growth to be muted this year.

Given the uncertainty surrounding the banking sector and JPM’s mixed momentum and sentiment, it could be wise to wait for a better entry point in the stock.

How Does JPMorgan Chase & Co. (JPM) Stack Up Against Its Peers?

JPM has an overall POWR Rating of C, equating to a Neutral rating. You may check out these A and B-rated stocks within the Foreign Banks industry: Banco Macro S.A. (BMA), Banco Santander, S.A. (SAN), and Nedbank Group Limited (NDBKY). For exploring more Buy-rated Foreign Banks stocks, click here.

What To Do Next?

43 year investment veteran, Steve Reitmeister, has just released his 2024 market outlook along with trading plan and top 11 picks for the year ahead.

2024 Stock Market Outlook >


JPM shares rose $0.54 (+0.27%) in premarket trading Monday. Year-to-date, JPM has gained 17.48%, versus a 9.41% rise in the benchmark S&P 500 index during the same period.


About the Author: Dipanjan Banchur


Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
JPMGet RatingGet RatingGet Rating
BMAGet RatingGet RatingGet Rating
SANGet RatingGet RatingGet Rating
NDBKYGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Will Stocks Continue to Rise...Or Time for Rug Pull?

It’s hard not to celebrate each new high for the S&P 500 (SPY). Yet with high inflation not dead and buried then perhaps this stock market celebration is a tad early. That is why you need to hear what 44 year investment veteran Steve Reitmeister is saying about what comes next for the stock market and how to stay on the right side of the action. Read on below for more...

4 Software Stocks Primed for Major Upside in 2024

The software industry is thriving, buoyed by digital transformation, soaring demand for cloud solutions, and the integration of advanced technologies like AI and ML, presenting lucrative opportunities for savvy investors. So, let’s look at tech stocks SS&C Technologies (SSNC), Informatica (INFA), Verint Systems (VRNT), and Yext (YEXT) poised for significant upside in 2024. Read on…

3 Pharma Stocks Primed for May Investment Opportunities

The pharma industry is poised for tremendous growth driven by surging healthcare needs, the introduction of groundbreaking medications, and relentless technological innovation. Hence, quality pharma stocks Collegium Pharmaceutical (COLL), Green Thumb Industries (GTBIF), and Bristol-Myers Squibb (BMY) emerge as prime investment options this month. Read more…

3 Bargain Internet Stock Buys for Savvy Investors

The increased internet penetration is reshaping various industries, driving digital transformation, connectivity, and access to services like e-commerce, remote work, and online entertainment. Thus, robust internet stocks Jamf Holding (JAMF), Upwork (UPWK), and TrueCar (TRUE), which are trading at discounts to their peers, could be ideal buys. Keep reading…

2 Paths for Stocks from Here

The recent rally for the S&P 500 (SPY) is nice to see. However, it is quite possible this is the end of the line for recent stock gains with more downside ahead. To explain the 2 distinct possibilities for stocks at this time is 44 year investment veteran Steve Reitmeister who shares this updated marketing outlook with trading plan and top picks in the article below...

Read More Stories

More JPMorgan Chase & Co. (JPM) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All JPM News